Sobo, patients can discuss weight-loss goals in a clinical setting where the emphasis is on health, not hype
Therefore, peptide analogs of GLP-1 have been developed to treat type 2 diabetes and obesity, with the beneficial outcome of lowering cardiovascular risks 10,11
Biochem Pharmacol (2021) 188:114578
Although some individuals have achieved this target, it is not common for most people.Losing 30 pounds in 3 months is possible with consistent use, healthy eating, and exercisebut results vary
Read the full article on:Efficacy and safety of onceweekly semaglutide versus oncedaily sitagliptin as addon to metformin in patients with type 2 diabetes in SUSTAIN China: A 30week, doubleblind, phase 3a, randomized trial Ji 2021 Diabetes, Obesity and Metabolism Wiley Online Library